Johnson & Johnson has kicked off a marketing application in the US for TAR-200 as a treatment ... based drug delivery system that allows for the continuous release of gemcitabine chemotherapy ...

TAR-200 is an intravesical drug releasing system that provides sustained local delivery of the chemotherapy drug gemcitabine into the bladder. The system is inserted into the bladder using a co ...

J&J's TAR-200 is an intravesical drug-releasing system that is placed in the bladder to provide sustained local delivery of the chemotherapy drug gemcitabine. TAR-200 is part of the Taris platform ...

J&J acquired rights to the silicone-based drug delivery device ... In the case of TAR-200, it it is being used to deliver the chemotherapy agent gemcitabine. In a statement, J&J said that the ...

If approved, TAR-200 will be the first intravesical drug-releasing ... method developed by J&J for a sustained delivery of chemotherapy drug gemcitabine directly into the bladder.

TAR-200 is an investigational intravesical drug releasing system designed to provide sustained local delivery of chemotherapy drug gemcitabine into the bladder. Johnson & Johnson NewsMORE Related ...